|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 |
| (11) | Patento numeris | 2920209 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13789492.9 |
| Europos patento paraiškos padavimo data | 2013-11-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-09-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-08-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2013/003399 |
| Data | 2013-11-12 |
| (87) | Numeris | WO 2014/075788 |
| Data | 2014-05-22 |
| (30) | Numeris | Data | Šalis |
| PCT/EP2012/0047 | 2012-11-13 | WO | |
| PCT/EP2013/0022 | 2013-07-30 | WO |
| (72) |
SAHIN, Ugur, DE
TÜRECI, Özlem, DE
STADLER, Christiane, DE
HOLLAND, Julia, DE
BÄHR-MAHMUD, Hayat, DE
BEISSERT, Tim, DE
PLUM, Laura, DE
LE GALL, Fabrice, DE
JENDRETZKI, Arne, DE
FIEDLER, Markus, DE
|
| (73) |
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige Gmb,
Freiligrathstrasse 12, 55131 Mainz,
DE
Astellas Pharma Inc., 5-1, Nihonbashi-Honcho 2-Chome, Chuo-ku Tokyo 103-8411, JP BioNTech SE, An der Goldgrube 12, 55131 Mainz, DE |
| (54) | AGENTS FOR TREATMENT OF CLAUDIN EXPRESSING CANCER DISEASES |
| AGENTS FOR TREATMENT OF CLAUDIN EXPRESSING CANCER DISEASES |